COVID-19 Impact on Global Mantle Cell Lymphoma Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 98 pages | ID: CAB45DB00A2DEN
QYResearch

Abstracts

This report focuses on the global Mantle Cell Lymphoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mantle Cell Lymphoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Astex Pharmaceuticals, Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• Cellular Biomedicine Group, Inc.
• Eisai
• EpiZyme, Inc.
• Fate Therapeutics, Inc.
• Genentech, Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline Plc
• Hutchison MediPharma Limited
• ImmunoGen, Inc.
• Immunomedics, Inc.

Market segment by Type, the product can be split into

• Acalabrutinib
• JCAR-017
• JNJ-64052781
• Acalisib
• IGN-002
• IMGN-529
• AFM-11
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Mantle Cell Lymphoma Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Mantle Cell Lymphoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Mantle Cell Lymphoma Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mantle Cell Lymphoma Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Acalabrutinib
  1.4.3 JCAR-017
  1.4.4 JNJ-64052781
  1.4.5 Acalisib
  1.4.6 IGN-002
  1.4.7 IMGN-529
  1.4.8 AFM-11
  1.4.9 Others
1.5 Market by Application
  1.5.1 Global Mantle Cell Lymphoma Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Mantle Cell Lymphoma Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Mantle Cell Lymphoma Treatment Industry
    1.6.1.1 Mantle Cell Lymphoma Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Mantle Cell Lymphoma Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Mantle Cell Lymphoma Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Mantle Cell Lymphoma Treatment Market Perspective (2015-2026)
2.2 Mantle Cell Lymphoma Treatment Growth Trends by Regions
  2.2.1 Mantle Cell Lymphoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Mantle Cell Lymphoma Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Mantle Cell Lymphoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Mantle Cell Lymphoma Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Mantle Cell Lymphoma Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Mantle Cell Lymphoma Treatment Players by Market Size
  3.1.1 Global Top Mantle Cell Lymphoma Treatment Players by Revenue (2015-2020)
  3.1.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio
  3.2.1 Global Mantle Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Mantle Cell Lymphoma Treatment Revenue in 2019
3.3 Mantle Cell Lymphoma Treatment Key Players Head office and Area Served
3.4 Key Players Mantle Cell Lymphoma Treatment Product Solution and Service
3.5 Date of Enter into Mantle Cell Lymphoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Mantle Cell Lymphoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Type (2021-2026)

5 MANTLE CELL LYMPHOMA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)
5.2 Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Mantle Cell Lymphoma Treatment Market Size (2015-2020)
6.2 Mantle Cell Lymphoma Treatment Key Players in North America (2019-2020)
6.3 North America Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
6.4 North America Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Mantle Cell Lymphoma Treatment Market Size (2015-2020)
7.2 Mantle Cell Lymphoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
7.4 Europe Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Mantle Cell Lymphoma Treatment Market Size (2015-2020)
8.2 Mantle Cell Lymphoma Treatment Key Players in China (2019-2020)
8.3 China Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
8.4 China Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Mantle Cell Lymphoma Treatment Market Size (2015-2020)
9.2 Mantle Cell Lymphoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
9.4 Japan Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Mantle Cell Lymphoma Treatment Market Size (2015-2020)
10.2 Mantle Cell Lymphoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Mantle Cell Lymphoma Treatment Market Size (2015-2020)
11.2 Mantle Cell Lymphoma Treatment Key Players in India (2019-2020)
11.3 India Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
11.4 India Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Mantle Cell Lymphoma Treatment Market Size (2015-2020)
12.2 Mantle Cell Lymphoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Astex Pharmaceuticals, Inc.
  13.1.1 Astex Pharmaceuticals, Inc. Company Details
  13.1.2 Astex Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Introduction
  13.1.4 Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020))
  13.1.5 Astex Pharmaceuticals, Inc. Recent Development
13.2 Bayer AG
  13.2.1 Bayer AG Company Details
  13.2.2 Bayer AG Business Overview and Its Total Revenue
  13.2.3 Bayer AG Mantle Cell Lymphoma Treatment Introduction
  13.2.4 Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  13.2.5 Bayer AG Recent Development
13.3 Bristol-Myers Squibb Company
  13.3.1 Bristol-Myers Squibb Company Company Details
  13.3.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
  13.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Introduction
  13.3.4 Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  13.3.5 Bristol-Myers Squibb Company Recent Development
13.4 Celgene Corporation
  13.4.1 Celgene Corporation Company Details
  13.4.2 Celgene Corporation Business Overview and Its Total Revenue
  13.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Introduction
  13.4.4 Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  13.4.5 Celgene Corporation Recent Development
13.5 Cellular Biomedicine Group, Inc.
  13.5.1 Cellular Biomedicine Group, Inc. Company Details
  13.5.2 Cellular Biomedicine Group, Inc. Business Overview and Its Total Revenue
  13.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Introduction
  13.5.4 Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  13.5.5 Cellular Biomedicine Group, Inc. Recent Development
13.6 Eisai
  13.6.1 Eisai Company Details
  13.6.2 Eisai Business Overview and Its Total Revenue
  13.6.3 Eisai Mantle Cell Lymphoma Treatment Introduction
  13.6.4 Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  13.6.5 Eisai Recent Development
13.7 EpiZyme, Inc.
  13.7.1 EpiZyme, Inc. Company Details
  13.7.2 EpiZyme, Inc. Business Overview and Its Total Revenue
  13.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Introduction
  13.7.4 EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  13.7.5 EpiZyme, Inc. Recent Development
13.8 Fate Therapeutics, Inc.
  13.8.1 Fate Therapeutics, Inc. Company Details
  13.8.2 Fate Therapeutics, Inc. Business Overview and Its Total Revenue
  13.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Introduction
  13.8.4 Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  13.8.5 Fate Therapeutics, Inc. Recent Development
13.9 Genentech, Inc.
  13.9.1 Genentech, Inc. Company Details
  13.9.2 Genentech, Inc. Business Overview and Its Total Revenue
  13.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Introduction
  13.9.4 Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  13.9.5 Genentech, Inc. Recent Development
13.10 Gilead Sciences, Inc.
  13.10.1 Gilead Sciences, Inc. Company Details
  13.10.2 Gilead Sciences, Inc. Business Overview and Its Total Revenue
  13.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Introduction
  13.10.4 Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  13.10.5 Gilead Sciences, Inc. Recent Development
13.11 GlaxoSmithKline Plc
  10.11.1 GlaxoSmithKline Plc Company Details
  10.11.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  10.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Introduction
  10.11.4 GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  10.11.5 GlaxoSmithKline Plc Recent Development
13.12 Hutchison MediPharma Limited
  10.12.1 Hutchison MediPharma Limited Company Details
  10.12.2 Hutchison MediPharma Limited Business Overview and Its Total Revenue
  10.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Introduction
  10.12.4 Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  10.12.5 Hutchison MediPharma Limited Recent Development
13.13 ImmunoGen, Inc.
  10.13.1 ImmunoGen, Inc. Company Details
  10.13.2 ImmunoGen, Inc. Business Overview and Its Total Revenue
  10.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Introduction
  10.13.4 ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  10.13.5 ImmunoGen, Inc. Recent Development
13.14 Immunomedics, Inc.
  10.14.1 Immunomedics, Inc. Company Details
  10.14.2 Immunomedics, Inc. Business Overview and Its Total Revenue
  10.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Introduction
  10.14.4 Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020)
  10.14.5 Immunomedics, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Mantle Cell Lymphoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Mantle Cell Lymphoma Treatment Revenue
Table 3. Ranking of Global Top Mantle Cell Lymphoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Mantle Cell Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acalabrutinib
Table 6. Key Players of JCAR-017
Table 7. Key Players of JNJ-64052781
Table 8. Key Players of Acalisib
Table 9. Key Players of IGN-002
Table 10. Key Players of IMGN-529
Table 11. Key Players of AFM-11
Table 12. Key Players of Others
Table 13. COVID-19 Impact Global Market: (Four Mantle Cell Lymphoma Treatment Market Size Forecast Scenarios)
Table 14. Opportunities and Trends for Mantle Cell Lymphoma Treatment Players in the COVID-19 Landscape
Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 16. Key Regions/Countries Measures against Covid-19 Impact
Table 17. Proposal for Mantle Cell Lymphoma Treatment Players to Combat Covid-19 Impact
Table 18. Global Mantle Cell Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 19. Global Mantle Cell Lymphoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 20. Global Mantle Cell Lymphoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 21. Global Mantle Cell Lymphoma Treatment Market Share by Regions (2015-2020)
Table 22. Global Mantle Cell Lymphoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 23. Global Mantle Cell Lymphoma Treatment Market Share by Regions (2021-2026)
Table 24. Market Top Trends
Table 25. Key Drivers: Impact Analysis
Table 26. Key Challenges
Table 27. Mantle Cell Lymphoma Treatment Market Growth Strategy
Table 28. Main Points Interviewed from Key Mantle Cell Lymphoma Treatment Players
Table 29. Global Mantle Cell Lymphoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 30. Global Mantle Cell Lymphoma Treatment Market Share by Players (2015-2020)
Table 31. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2019)
Table 32. Global Mantle Cell Lymphoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 33. Key Players Headquarters and Area Served
Table 34. Key Players Mantle Cell Lymphoma Treatment Product Solution and Service
Table 35. Date of Enter into Mantle Cell Lymphoma Treatment Market
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. Global Mantle Cell Lymphoma Treatment Market Size Share by Type (2015-2020)
Table 39. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2021-2026)
Table 40. Global Mantle Cell Lymphoma Treatment Market Size Share by Application (2015-2020)
Table 41. Global Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. Global Mantle Cell Lymphoma Treatment Market Size Share by Application (2021-2026)
Table 43. North America Key Players Mantle Cell Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 44. North America Key Players Mantle Cell Lymphoma Treatment Market Share (2019-2020)
Table 45. North America Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. North America Mantle Cell Lymphoma Treatment Market Share by Type (2015-2020)
Table 47. North America Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. North America Mantle Cell Lymphoma Treatment Market Share by Application (2015-2020)
Table 49. Europe Key Players Mantle Cell Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 50. Europe Key Players Mantle Cell Lymphoma Treatment Market Share (2019-2020)
Table 51. Europe Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. Europe Mantle Cell Lymphoma Treatment Market Share by Type (2015-2020)
Table 53. Europe Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. Europe Mantle Cell Lymphoma Treatment Market Share by Application (2015-2020)
Table 55. China Key Players Mantle Cell Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 56. China Key Players Mantle Cell Lymphoma Treatment Market Share (2019-2020)
Table 57. China Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. China Mantle Cell Lymphoma Treatment Market Share by Type (2015-2020)
Table 59. China Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. China Mantle Cell Lymphoma Treatment Market Share by Application (2015-2020)
Table 61. Japan Key Players Mantle Cell Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 62. Japan Key Players Mantle Cell Lymphoma Treatment Market Share (2019-2020)
Table 63. Japan Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Japan Mantle Cell Lymphoma Treatment Market Share by Type (2015-2020)
Table 65. Japan Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Japan Mantle Cell Lymphoma Treatment Market Share by Application (2015-2020)
Table 67. Southeast Asia Key Players Mantle Cell Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 68. Southeast Asia Key Players Mantle Cell Lymphoma Treatment Market Share (2019-2020)
Table 69. Southeast Asia Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. Southeast Asia Mantle Cell Lymphoma Treatment Market Share by Type (2015-2020)
Table 71. Southeast Asia Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. Southeast Asia Mantle Cell Lymphoma Treatment Market Share by Application (2015-2020)
Table 73. India Key Players Mantle Cell Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 74. India Key Players Mantle Cell Lymphoma Treatment Market Share (2019-2020)
Table 75. India Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. India Mantle Cell Lymphoma Treatment Market Share by Type (2015-2020)
Table 77. India Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. India Mantle Cell Lymphoma Treatment Market Share by Application (2015-2020)
Table 79. Central & South America Key Players Mantle Cell Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 80. Central & South America Key Players Mantle Cell Lymphoma Treatment Market Share (2019-2020)
Table 81. Central & South America Mantle Cell Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 82. Central & South America Mantle Cell Lymphoma Treatment Market Share by Type (2015-2020)
Table 83. Central & South America Mantle Cell Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 84. Central & South America Mantle Cell Lymphoma Treatment Market Share by Application (2015-2020)
Table 85. Astex Pharmaceuticals, Inc. Company Details
Table 86. Astex Pharmaceuticals, Inc. Business Overview
Table 87. Astex Pharmaceuticals, Inc. Product
Table 88. Astex Pharmaceuticals, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 89. Astex Pharmaceuticals, Inc. Recent Development
Table 90. Bayer AG Company Details
Table 91. Bayer AG Business Overview
Table 92. Bayer AG Product
Table 93. Bayer AG Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 94. Bayer AG Recent Development
Table 95. Bristol-Myers Squibb Company Company Details
Table 96. Bristol-Myers Squibb Company Business Overview
Table 97. Bristol-Myers Squibb Company Product
Table 98. Bristol-Myers Squibb Company Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 99. Bristol-Myers Squibb Company Recent Development
Table 100. Celgene Corporation Company Details
Table 101. Celgene Corporation Business Overview
Table 102. Celgene Corporation Product
Table 103. Celgene Corporation Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 104. Celgene Corporation Recent Development
Table 105. Cellular Biomedicine Group, Inc. Company Details
Table 106. Cellular Biomedicine Group, Inc. Business Overview
Table 107. Cellular Biomedicine Group, Inc. Product
Table 108. Cellular Biomedicine Group, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 109. Cellular Biomedicine Group, Inc. Recent Development
Table 110. Eisai Company Details
Table 111. Eisai Business Overview
Table 112. Eisai Product
Table 113. Eisai Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 114. Eisai Recent Development
Table 115. EpiZyme, Inc. Company Details
Table 116. EpiZyme, Inc. Business Overview
Table 117. EpiZyme, Inc. Product
Table 118. EpiZyme, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 119. EpiZyme, Inc. Recent Development
Table 120. Fate Therapeutics, Inc. Business Overview
Table 121. Fate Therapeutics, Inc. Product
Table 122. Fate Therapeutics, Inc. Company Details
Table 123. Fate Therapeutics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 124. Fate Therapeutics, Inc. Recent Development
Table 125. Genentech, Inc. Company Details
Table 126. Genentech, Inc. Business Overview
Table 127. Genentech, Inc. Product
Table 128. Genentech, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 129. Genentech, Inc. Recent Development
Table 130. Gilead Sciences, Inc. Company Details
Table 131. Gilead Sciences, Inc. Business Overview
Table 132. Gilead Sciences, Inc. Product
Table 133. Gilead Sciences, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 134. Gilead Sciences, Inc. Recent Development
Table 135. GlaxoSmithKline Plc Company Details
Table 136. GlaxoSmithKline Plc Business Overview
Table 137. GlaxoSmithKline Plc Product
Table 138. GlaxoSmithKline Plc Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 139. GlaxoSmithKline Plc Recent Development
Table 140. Hutchison MediPharma Limited Company Details
Table 141. Hutchison MediPharma Limited Business Overview
Table 142. Hutchison MediPharma Limited Product
Table 143. Hutchison MediPharma Limited Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 144. Hutchison MediPharma Limited Recent Development
Table 145. ImmunoGen, Inc. Company Details
Table 146. ImmunoGen, Inc. Business Overview
Table 147. ImmunoGen, Inc. Product
Table 148. ImmunoGen, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 149. ImmunoGen, Inc. Recent Development
Table 150. Immunomedics, Inc. Company Details
Table 151. Immunomedics, Inc. Business Overview
Table 152. Immunomedics, Inc. Product
Table 153. Immunomedics, Inc. Revenue in Mantle Cell Lymphoma Treatment Business (2015-2020) (Million US$)
Table 154. Immunomedics, Inc. Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Mantle Cell Lymphoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Acalabrutinib Features
Figure 3. JCAR-017 Features
Figure 4. JNJ-64052781 Features
Figure 5. Acalisib Features
Figure 6. IGN-002 Features
Figure 7. IMGN-529 Features
Figure 8. AFM-11 Features
Figure 9. Others Features
Figure 10. Global Mantle Cell Lymphoma Treatment Market Share by Application: 2020 VS 2026
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Mantle Cell Lymphoma Treatment Report Years Considered
Figure 15. Global Mantle Cell Lymphoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Mantle Cell Lymphoma Treatment Market Share by Regions: 2020 VS 2026
Figure 17. Global Mantle Cell Lymphoma Treatment Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Mantle Cell Lymphoma Treatment Market Share by Players in 2019
Figure 20. Global Top Mantle Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mantle Cell Lymphoma Treatment as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Mantle Cell Lymphoma Treatment Revenue in 2019
Figure 22. North America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Mantle Cell Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Mantle Cell Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Mantle Cell Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Mantle Cell Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Mantle Cell Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Mantle Cell Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Astex Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Astex Pharmaceuticals, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 31. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bayer AG Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 33. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bristol-Myers Squibb Company Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 35. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Celgene Corporation Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 37. Cellular Biomedicine Group, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 39. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Eisai Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 41. EpiZyme, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. EpiZyme, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 43. Fate Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Fate Therapeutics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 45. Genentech, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Genentech, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 47. Gilead Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Gilead Sciences, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 49. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GlaxoSmithKline Plc Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 51. Hutchison MediPharma Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Hutchison MediPharma Limited Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 53. ImmunoGen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. ImmunoGen, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 55. Immunomedics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Immunomedics, Inc. Revenue Growth Rate in Mantle Cell Lymphoma Treatment Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed